Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other Non-Current Assets (2022 - 2025)

Treace Medical Concepts (TMCI) has disclosed Other Non-Current Assets for 4 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 200.0% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Dec 2025, up 200.0%, and an annual FY2025 reading of $1.2 million, up 200.0% over the prior year.
  • Other Non-Current Assets was $1.2 million for Q4 2025 at Treace Medical Concepts, up from $614000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.2 million in Q4 2025 and bottomed at $134000.0 in Q1 2022.
  • Average Other Non-Current Assets over 4 years is $329250.0, with a median of $146000.0 recorded in 2022.
  • The sharpest move saw Other Non-Current Assets tumbled 32.09% in 2024, then surged 363.01% in 2025.
  • Year by year, Other Non-Current Assets stood at $146000.0 in 2022, then changed by 0.0% to $146000.0 in 2023, then surged by 178.77% to $407000.0 in 2024, then skyrocketed by 200.0% to $1.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for TMCI at $1.2 million in Q4 2025, $614000.0 in Q3 2025, and $676000.0 in Q2 2025.